Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive th...

por Bai, Haiyan, Padron, Alvaro S, Deng, Yilun, Liao, Yiji J, Murray, Clare J, Ontiveros, Carlos, Kari, Suresh J, Kancharla, Aravind, Kornepati, Anand V R, Garcia, Myrna, Reyes, Ryan Michael, Gupta, Harshita B, Conejo-Garcia, Jose R, Curiel, Tyler
Publicado 2023

CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation

por Reyes, Ryan Michael, Deng, Yilun, Zhang, Deyi, Ji, Niannian, Mukherjee, Neelam, Wheeler, Karen, Gupta, Harshita B, Padron, Alvaro S, Kancharla, Aravind, Zhang, Chenghao, Garcia, Myrna, Kornepati, Anand V R, Boyman, Onur, Conejo-Garcia, Jose R, Svatek, Robert S, Curiel, Tyler J
Publicado 2021